GSK2330811
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2330811, covering 2017-05-15 to 2021-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis [Phase 2]